| Data | Descrição | Vacina | Quantidade 1° dose | Quantidade 2° dose | Quantidade 1° dose extra | Quantidade 2° dose extra | Quantidade de doses indigena | Total |
| 04/11/2021 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 558 |
| 04/11/2021 | REMESSA | Covid-19-Coronavac-Sinovac/Butantan | 0 | 10 | 0 | 0 | 0 | 10 |
| 19/11/2021 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 480 | 0 | 0 | 0 | 1.392 |
| 23/11/2021 | REMESSA | Covid-19-Coronavac-Sinovac/Butantan | 30 | 0 | 0 | 0 | 0 | 30 |
| 23/11/2021 | REMESSA | Covid-19-Coronavac-Sinovac/Butantan | 0 | 10 | 0 | 0 | 0 | 10 |
| 25/11/2021 | REMESSA | Covid-19-AstraZeneca | 0 | 395 | 0 | 0 | 0 | 395 |
| 25/11/2021 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 960 |
| 03/12/2021 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 828 | 294 | 0 | 0 | 0 | 3.006 |
| 03/12/2021 | REMESSA | Covid-19-Coronavac-Sinovac/Butantan | 180 | 0 | 0 | 0 | 0 | 180 |
| 13/12/2021 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 612 | 0 | 0 | 0 | 2.178 |
| 13/12/2021 | REMESSA | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 120 | 0 | 0 | 0 | 0 | 120 |
| 13/12/2021 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 6 |
| 17/12/2021 | REMESSA | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 540 | 0 | 0 | 0 | 0 | 540 |
| 23/12/2021 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 204 | 0 | 0 | 0 | 3.168 |
| 15/01/2022 | REMESSA | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 0 | 0 | 0 | 0 | 0 | 300 |
| 15/01/2022 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 252 | 0 | 0 | 0 | 1.710 |
| 15/01/2022 | REMESSA PEDIATRICA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 460 | 0 | 0 | 0 | 0 | 460 |
| 21/01/2022 | REMESSA | PFIZER PEDIÁTRICA | 1.000 | 0 | 0 | 0 | 0 | 1.000 |
| 21/01/2022 | REMESA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 414 | 0 | 0 | 0 | 1.986 |
| 28/01/2022 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 528 |
| 04/02/2022 | REMESSA | Covid-19-AstraZeneca | 0 | 0 | 0 | 0 | 0 | 775 |
| 04/02/2022 | REMESSA | Covid-19-Coronavac-Sinovac/Butantan | 0 | 0 | 0 | 0 | 0 | 150 |
| 04/02/2022 | REMESSA | Covid-19-Coronavac-Sinovac/Butantan | 0 | 150 | 0 | 0 | 0 | 150 |
| 04/02/2022 | REMESSA | Covid-19-Coronavac-Sinovac/Butantan | 150 | 0 | 0 | 0 | 0 | 150 |
| 09/02/2022 | REMESSA | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 835 | 0 | 0 | 0 | 0 | 835 |
| 16/02/2022 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 0 | 0 | 0 | 0 | 12 |
| 18/02/2022 | REMESSA | Covid-19-AstraZeneca | 0 | 10 | 0 | 0 | 0 | 1.390 |
| 18/02/2022 | REMESSA | Vacina covid-19 - Ad26.COV2.S - Janssen-Cilag | 830 | 0 | 0 | 0 | 0 | 830 |
| 23/02/2022 | REMESSA | Vacina covid-19 - BNT162b2 - BioNTech/Fosun Pharma/Pfizer | 0 | 523 | 0 | 0 | 0 | 523 |
| 23/02/2022 | REMESSA | Covid-19-Coronavac-Sinovac/Butantan | 0 | 500 | 0 | 0 | 0 | 500 |
